Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Finished Goods (2019 - 2022)

Historic Finished Goods for Marimed (MRMD) over the last 4 years, with Q1 2022 value amounting to $5.3 million.

  • Marimed's Finished Goods rose 7087.55% to $5.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $5.3 million, marking a year-over-year increase of 7087.55%. This contributed to the annual value of $3.8 million for FY2021, which is 3517.18% up from last year.
  • As of Q1 2022, Marimed's Finished Goods stood at $5.3 million, which was up 7087.55% from $3.8 million recorded in Q4 2021.
  • Marimed's Finished Goods' 5-year high stood at $5.8 million during Q3 2021, with a 5-year trough of $518166.0 in Q4 2019.
  • In the last 4 years, Marimed's Finished Goods had a median value of $3.8 million in 2021 and averaged $3.8 million.
  • In the last 5 years, Marimed's Finished Goods skyrocketed by 44681.92% in 2020 and then soared by 3517.18% in 2021.
  • Over the past 4 years, Marimed's Finished Goods (Quarter) stood at $518166.0 in 2019, then surged by 446.82% to $2.8 million in 2020, then skyrocketed by 35.17% to $3.8 million in 2021, then skyrocketed by 37.47% to $5.3 million in 2022.
  • Its last three reported values are $5.3 million in Q1 2022, $3.8 million for Q4 2021, and $5.8 million during Q3 2021.